On-Demand Webinars

  1. Raising The Bar In Gene Therapy 12/1/2025

    Learn how a science-driven and digitally structured approach reduced onboarding timelines for gene therapy from 12 months to just 3, setting a new benchmark in technology transfers.

  2. Class 3 Atropisomers: Capture Therapeutic Selectivity In Oncology 11/26/2025

    Atropisomers are key to modern small molecule drug development. Learn how advanced manufacturing strategies enable the isolation and scalable production of the most effective single isomer.

  3. Extrusion-Based ASD Scale-Up: Performance Through Process Understanding 11/20/2025

    Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

  4. Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions 11/20/2025

    Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.

  5. Are You Keeping Pace With Oligo Synthesis Optimization? 11/18/2025

    The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

  6. From Readiness To Results: Unlocking Capacity For Expanding Product Demand 11/18/2025

    Learn the six pillars that bridge operational readiness and operational excellence. Discover a proven framework to build a resilient, high-performing manufacturing operation and unlock necessary capacity.

  7. Advancing Topical Formulations With Innovative Preclinical Models 11/17/2025

    A robust formulation development approach integrates scientific principles, systematic formulation development, and preclinical models to facilitate early identification of candidates with poor developability.

  8. Accelerating Early Phase Biologics From The Clinic To Commercialization 11/13/2025

    Strategic planning in early-phase biologics accelerates clinical progress, reduces risk, and lays the groundwork for scalable, compliant manufacturing and successful commercialization.

  9. Accelerate Your pDNA And mRNA Process Development 11/13/2025

    Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

  10. Driving Robust Tech Transfer In Biologics: CFD Simulation 11/12/2025

    Computational Fluid Dynamics simulation is essential for robust biologics tech transfer. See how this predictive tool optimizes critical scale-up processes, reducing risk and expediting time to market.